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Studies on the mechanism whereby acidemia stimulates collecting duct
hydrogen ion secretion in vivo. The purpose of these studies was to
elucidate the mechanism whereby collecting duct hydrogen ion secre-
tion was augmented by acidemia. The urine minus blood Pco, differ-
ence in alkaline urine (U-B Pco) was used to evaluate this parameter.
in dogs with a normal ECF volume, the U-B Pco2 was high, and there
was no significant relationship between the U-B Pco, factored for the
urine bicarbonate concentration and the blood hydrogen ion concentra-
tions unless amiloride, an agent that abolishes the transtubular potential
difference, was present. In this latter case, the U-B Pco2 was a linear
function of the urine bicarbonate concentration, and the U-B Pco,
factored for the urine bicarbonate concentration was directly propor-
tional to the blood hydrogen ion concentration. To extend the pH
range considerably, we used lysine to induce bicarbonaturia in dogs
with an expanded ECF volume. Amiloride now caused only a small
decrease in the U-B Pco, at any urine bicarbonate concentration, and
furthermore, it did not influence the linear relationship between the U-B
Pco2 factored for the urine bicarbonate concentration and the blood
hydrogen ion concentration. These results suggest that acidemia stimu-
lates collecting duct hydrogen ion secretion by a mechanism that
appears to be independent of the amiloride-sensitive component of the
U-B Pco2. We speculate that the mechanism might involve an increased
intracellular hydrogen ion concentration during acidemia.
Etude du mécanisme par lequel l'acidémie stimule Ia sécrétion d'ion
hydrogene par le canal collecteur in vivo. Le but de cc travail est
d'éiucider le mCcanisme par lequel Ia sécrétion d'ion hydrogene est
augmentée par l'acidémie. La difference urine-sang de Pco2 en urine
alcaline (U-B Pco2) a Cté utilisëe pour évaluer cc paramètre. Chez des
chiens avec un volume extracellulaire (ECF) normal, La difference U-B
Pco2 est élevée et il n'y a pas de relation significative entre cette
difference rapportCe a Ia concentration urinaire de bicarbonate et Ia
concentration sanguine d'ion hydrogéne sauf quand de l'amiloride, un
agent qui abolit Ia difference de potentiel transtubulaire, est administri.
Dans cc cas Ia difference U-B Pco est une fonction linéaire de Ia
concentration urinaire de bicarbonate et U-B Pco2 rapportee a Ia
concentration de bicarbonate urinaire est directement proportionnelle a
Ia concentration sanguine d'ion hydrogene. Afin d'étendre
considérablement l'éventail de pH Ia lysine a été employee pour
determiner une bicarbonaturie chez Ic chien dont Ic volume extracellu-
laire est augmentC. Dans cette situation. l'amiloride ne determine
qu'une faible diminution de U-B Pco, a n'importe quelle concentration
urinaire de bicarbonate, et, de plus. il n'influence pas Ia relation linéaire
entre U-B Pco2 rapportee a Ia concentration de bicarbonate urinaire et
Ia concentration sanguine d'ion hydrogène. Ces résultats suggèrent que
l'acidémie stimule Ia secretion d'ion hydrogene par Ic canal collecteur
par un mécanisme qui parait independant de Ia composante sensible a
I'amiloride de U-B Pco. Nous faisons l'hypothese que cc mCcanisme
peut impliquer une augmentation de Ia concentration intracellulaire
d'ion hydrogène au coors de l'acidémie.
Hydrogen ion secretion by the distal portion of the nephron is
fundamentally important for net acid excretion and thus is
critical for the defence of acid-base balance. The majority of
information relating to the hydrogen ion secretory process has
been gathered "in vitro" using reptilian or amphibian urinary
bladders as analogues of collecting duct cells (for review, see
Refs. 1 and 2). The general conclusion from these studies is that
there is a specific proton pump that adds hydrogen ions to
lumenal fluid. The magnitude of the response of this pump is
increased by either an increased intracellular or decreased
lumenal hydrogen ion concentration or a larger lumen-negative
transtubular potential difference. This latter augmentation of
secretion should be inhibited by amiloride, a natriuretic agent
studied in considerable detail both in vitro and in vivo [3—Il].
Amiloride inhibits sodium transport and abolishes the lumen
negative transtubular potential difference, but it does not ap-
pear to influence that portion of hydrogen ion secretion that is
independent of the electrical gradient, either in vivo or in vitro
[10, 11].
We have recently established that collecting duct hydrogen
ion secretion, as estimated by the urine minus arterial blood
Pco2 difference in alkaline urine, (U-B Pco2) is increased during
acidemia [121. The purpose of the present study was to consider
whether acidemia stimulates this parameter in vivo by influenc-
ing the amiloride-sensitive component of hydrogen ion secre-
tion. To answer this question, we used amiloride under condi-
tions where bicarbonaturia existed over a narrow range of blood
pH. This range was then extended by infusing various ionic
forms of lysine to induce a proximal renal tubular acidosis [12,
13]. Results to be reported suggest that acidemia stimulates
collecting duct hydrogen ion secretion by increasing the hydro-
gen ion concentration in the cell.
Methods
Experimental procedures. Studies were performed on 42
female mongrel dogs ranging in weight from 10 to 30 kg.
Following an overnight fast, animals were anesthetized with i.v.
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Table 1. Representative experiments depicting effects of amiloride and amiloride plus lysine infusions
Blood Urine
HCO3 K HCO3 Na K
Pco2 Pco2
Exp. pH mm Hg mEqiliter pH mm Hg mEq/liter
V U-B Pco2
mI/mm mm Hg
Normal dog infused with 0.15 si NaHCO
A 7.40 35 21 3,5 7.98 120 407 370 254 0.2 85
7.41 36 22 3.3 7.94 121 367 343 241 0.4 85
7.41 37 23 3.2 8.01 121 460 433 240 0.2 84
Infused with amilorideb
7.40 37 22 3.5 8.02 80 280 525 6 0.5 43
7.41 33 20 3.6 8.09 89 376 563 3 0.5 56
7.38 35 20 3.5 8.00 75 242 482 6 0.5 40
Normal dog infused with amiloride for 60 mm
B 7.38 35 20 3.8 7.79 66 102 223 12 0.5 31
Start infusion of L-lySifle monohydrochloride, 55 imo1es/kgImin
7.35 39 21 3.6 7,61 95 89 145 7 0.7 56
7.35 36 19 4.4 7.46 117 67 70 3 1.2 81
7,33 38 19 5.0 7.38 107 49 57 4 2.5 69
7.31 37 18 5.3 7.42 122 64 77 7 2.3 85
7.31 39 19 6.8 7.38 118 60 110 10 3.4 79
7.29 35 16 7.7 7.36 111 56 124 11 5.3 76
7.24 39 16 7.9 7.37 113 59 128 11 5.0 74
Normal dog infused with amiloride for 60 mm
C 7.37 36 20 3.4 7.85 53 90 182 5 0.6 17
Start mnfision of isoelectric L-lysine, 55 pmoles/kg/min
7.40 36 22 3.6 7.66 79 83 166 1 1.6 43
7.41 38 23 4.2 7.62 97 94 171 2 3.2 59
7.41 39 24 4.3 7.62 87 84 165 3 5.6 48
7.39 40 24 4.6 7.66 89 94 166 3 7.4 49
7.40 39 23 4.7 7,66 89 96 166 4 7.6 50
7.40 40 24 5.0 7.64 93 95 167 4 7.8 53
7.39 39 23 5.2 7.65 93 95 162 4 7.5 54
a Results are recorded at 20-mm intervals.
A period of 30 mm elapsed before obtaining samples at 20-mm intervals.
Table 2. Mean blood and urine parameters in amiloride-treated dogsa
Lysine infused
No lysine (N = 25) Acidemic (N = 103) Normal (N = 50) Alkalemic (N = 52)
Blood pH 7.43 0.01 7.26 0.OU' 7.40 0.01 7.48 0.Olh
Arterial Pco2, mm Hg 35 1 37 1 36 I 38 I
Plasma bicarbonate, mEqiliter 23 1 16 0.4b 21 0.5 28 0.5b
Plasma potassium, mEq/liier 4.2 0.1 6.5 0.2b 4.2 0.1 4.1 0,1
Urine flow, mI/mm 0.9 0.1 5.6 0.4 4.5 0.4 7.4 0.6"
Urine pH 7.85 0.04 7.42 0.01" 7.64 0.02 7.84 0.Olb
Urine bicarbonate, mEqlliler 190 9 48 3" 77 5 134 5b
Urine potassium, mEqiliter 11 3 6 1 5 1 11 lb
Buffer capacityc 6 1 2.5 0.3" 3.1 0.3 2.3 0.5
GFR, mi/mm 49 3 57 2 55 3 56 3
U-B Pco2, mm Hg 58 3 46 3 42 3 44 3
U-B PCO2/UHCO3 0.32 0.02 1.00 0.03" 0.57 0.03 0.33 0.Olb
a Values are means SEM.
b p < 0.01, a significant difference in the presence of lysine either between the acidemic group and the normal group or between the alkalemic
group and the normal group.
Buffer capacity was measured in mEq/liter/0.5 pH unit below final urine pH.
sodium pentobarbital (30 mg/kg of body wt plus small additional prevent arterial Pco2 variations during the remainder of the
doses whenever necessary during the experiment). A cuffed experiments.
endotracheal tube was inserted into the trachea, and this was Urine was collected under mineral oil through an indwelling
connected to a Harvard respirator. Respiratory rate and depth bladder catheter. Manual suprapubic compression was used to
were initially adjusted to maintain arterial carbon dioxide empty the bladder at the end of each collection period. Each 20-
tension around 35 mm Hg. No further attempts were made to mm clearance period was bracketed by arterial blood samples
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that were analyzed for acid-base parameters as soon as blood
had been drawn anaerobically through an indwelling catheter
inserted into the femoral artery.
Group 1: Dogs infused with isotonic sodium bicarbonate.
This group consisted of 8 dogs infused with isotonic sodium
bicarbonate throughout the experiment at a rate that ranged
between 0.2 to 1.0 ml/min, and this was approximately equal to
the urine flow rate. After a period of at least 60 mm, during
which three control samples were obtained, all dogs were then
infused with amiloride as an initial bolus of 1 mg/kg of body wt
over a 5-mm period, and this was followed by an infusion of 2.4
mg/kg of body wt per hour.
Group 2: Dogs infused with amiloride and lysine. This group
consisted of 34 dogs infused with an isotonic solution made up
of equal amounts of 5% mannitol and 0.9% sodium chloride at a
rate of 2 mI/mm throughout the experiment. Amiloride was
given as described above. A period of at least 60 mm was then
allowed to elapse before three consecutive 20-mm control
clearance periods were obtained. Following this control period,
each animal was infused with a 0.5 M L-lysine solution to obtain
simultaneously an alkaline urine and widely varying blood pH
values. L-Lysine monohydrochloride was infused at a rate of 55
moles/kg/min into 10 dogs and at a rate of 110 pmoles/kg/min
into 13 other dogs. Four dogs were given isoelectric L-lysine,
and seven dogs were infused with sodium L-lysinate. Isoelectric
L-lysine and sodium L-lysinate were prepared from L-lysine
monohydrochioride solution by adding adequate amounts of
sodium hydroxide, as previously described [12]. L-LySifle
monohydrochloride was obtained from Eastman Kodak Co.,
Rochester, New York.
To prevent the generation of a high urine Pco2 from mixing of
acid and alkaline urines in the lower urinary tract, we accepted
only urine samples that contained at least 20 m bicarbonate
and that had a pH that differed from the adjacent urine
collection by less than 0.20 pH unit.
Analytical methods and calculations. The pH and Pco2 of
blood and urine were determined anaerobically at 38° C with a
digital acid-base analyzer (Radiometer, model PHM 72). Plasma
bicarbonate concentration was calculated using a solubility
coefficient of 0,0301 and pK' of 6.10, whereas in the urine, the
solubility factor was 0.0309 and the pK' was calculated from
urinary ionic strength (6.33 — 0.5 \/(Na) + (K), with the
concentrations of sodium and potassium given in equivalents
per liter) [14].
Analytical methods used for determining sodium, potassium,
chloride, phosphate, and creatinine concentrations and the
urine buffer capacity have been described previously [12].
Exogenous creatinine clearance was used to estimate glomeru-
tar filtration rate.
Statistical analysis. Unless otherwise specified, the term
significant is used throughout the paper to describe a difference
with a P value of less than 0.01 as determined by Student's t test
for paired or unpaired data. The regression lines were calculat-
ed by the method of least squares. Comparison of the slopes of
the regression lines was performed by an analysis of covariance
as described by Snedecor and Cochran [15].
Results
Group 1: Dogs infused with a small load of isotonic sodium
bicarbonate solution. Dogs infused with a small quantity of
Fig. 2. Effect of blood hydrogen ion concentration on the U-B Pco2
factored by the urine bicarbonate concentration in the presence of
amiloride in dogs infused with isotonic sodium bicarbonate solution.
The regression line depicting the relationship in dogs infused with
amiloride is U-B PC02/UHCO3 0.032 blood [H] — 0.91, (N = 66, r =
0.73, P < 0.01).
bicarbonate remained in sodium balance and had a high U-B
Pco2. This U-B Pco2 was significantly reduced when amiloride
was infused. Amiloride also caused a marked decline in the
urine potassium concentration and a significant increase in the
urine volume and sodium excretion rate (Tables 1 and 2). When
the results from 8 dogs were evaluated, there was no effect of
blood hydrogen ion concentration on the U-B Pco2 or the U-B
Pco2 factored for the urine bicarbonate concentration before
amiloride was infused (Fig. 1). But, in the presence of aniilor-
ide, there was now a significant direct relationship between the
U-B Pco2 factored for the urine bicarbonate concentration and
the blood hydrogen ion concentration (Fig. 2).
Group 2: Dogs infused with amiloride and lysine. Two
hundred and five urine samples in which the bicarbonate
a
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Fig. 1. Effect of blood hydrogen ion concentration on the U-B Pco2
factored by the urine bicarbonate concentration in dogs infused with
isotonic sodium bicarbonate solution. For description, see methods
section. The regression line depicting this relationship is U-B Pco2/
UHCO 0.005 blood [HJ + 0.28, (N = 72, r = 0.11).
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Fig. 4. Effect of urine bicarbonate concentration on the U-B Pco2
during lysine infusion into a,niloride-treated dogs with a blood pH
between 7.36 and 7.43, The regression line is U-B Pco2 0.43 UHCO3 +
8.8 (N = 50, r = 0.71, p <0.01). The dashed line indicates the
regression line (Y = 0.56x + 20.4) obtained in dogs infused with lysine
having a blood pH between 7.36 and 7.43 in the absence of amiloride
[12].
concentration exceeded 20 m were obtained from the 34 dogs.
Because the infusion of various ionic forms of lysine resulted in
a wide range of blood pH values (from 7.06 to 7.64), the urine
samples were divided into three groups according to the ob-
served blood pH value: blood pH lower than 7.36 (acidemia),
blood pH between 7.36 and 7.43 (normal), and blood pH
exceeding 7.43 (alkalemia) (see Tables 1 and 2). In these three
groups, the U-B Pco2 correlated significantly with the urine
bicarbonate concentration (Figs. 3—5). Therefore, this relation-
ship between the U-B Pco2 and the urine bicarbonate concen-
tration, already shown during the infusion of either sodium
bicarbonate [11, 16—18] or lysine [12] was not disrupted by the
administration of amiloride.
At similar urine bicarbonate concentrations, the U-B Pco2
was significantly higher during acidemia (Fig. 3) than it was at
either a normal (Fig. 4) or alkaline blood pH (Fig. 5). In
addition, the slope of the linear regression depicting the rela-
tionship between the U-B Pco2 and the urine bicarbonate
concentration was significantly steeper during acidemia (0.79)
than it was when blood pH was either normal (0.43) or alkaline
(0.44). This steeper slope in acidemia suggested a relationship
between the U-B Pco2 at a given urine bicarbonate concentra-
tion and the blood hydrogen ion concentration, and indeedT there was a direct relationship between these parameters as
depicted in Fig. 6.
Discussion
Model to study hydrogen ion secretion in vivo. Hydrogen ion
secretion in the collecting duct occurs on a proton-specific
pump, and the magnitude of this process is influenced by the
prevailing chemical gradients and transtubular potential differ-
ence (for review, see Refs. I and 2). A more favorable chemical
gradient for hydrogen ion secretion could occur if the intracellu-
lar fluid pH became more acid or the lumenal fluid pH more
alkaline. Similarly, a lumen-negative transtubular potential dif-
ference in this nephron segment would theoretically augment
hydrogen ion secretion. Such a gradient is produced when
sodium but not its accompanying anion is actively reabsorbed
(providing that this gradient is not dissipated by concomitant
potassium secretion). Sodium reabsorption in the collecting
duct is dependent upon adequate sodium delivery and an
appropriate stimulus to promote its reabsorption (for review,
see Ref. 19).
Amiloride has been used to clarify aspects of the regulation of
hydrogen ion secretion in the collecting duct and in "in vitro"
models of this nephron site [3—Il]. This agent inhibits sodium
transport in these tissues and as a result, should prevent the
generation of a lumen-negative transtubular potential difference
that would augment the response of the proton pump. Further-
more, amiloride does not appear to influence that component of
hydrogen ion secretion that is independent of the transtubular
potential difference induced by sodium reabsorption (that is,
hydrogen ion secretion in the short-circuited urinary bladder or
proton secretion induced by an exogenously applied electrical
gradient). Based on these considerations, we suggest that the
magnitude of the electrical augmentation of hydrogen ion
secretion produced by sodium reabsorption could be estimated
by comparing results before and after amiloride administration.
In recent studies [3, 11], we have shown that the amiloride-
sensitive component of the U-B Pco2 was quite large in dogs
with a contracted ECF volume or in normovolemic dogs when
the urine bicarbonate concentration was less than 60 mrvi.
Amiloride also reduced the U-B Pco7 in normovolemic dogs
excreting a urine with a much higher bicarbonate concentration,
but in this case the decline was of a somewhat smaller propor-
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Flg 3. Effect of urine bicarbonate concentration on the U-B Pco2
during lysine infusion into amiloride-treated dogs with a blood pH
lower than 7.36. The regression line during acidemia is U-B Pco2 = 0.79
UHCO3 + 8.8 (N = 103, r = 0.81, P < 0.01). The dashed line represents
the regression line (Y = I .26x + 14.7) obtained in acidemic dogs infused
with lysine in the absence of amiloride [121.
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tion. In dogs with an expanded ECF volume, amiloride had
little effect on the U-B Pco2. These results are compatible with
but do not prove the conclusion that there was little role for the
transtubular potential difference in controlling collecting duct
hydrogen ion secretion in dogs with an expanded ECF volume
and that other forces favoring proton secretion were the pre-
dominant influence on the magnitude of the U-B Pco2 at this
time. Should the hydrogen ion concentration gradient be impor-
tant, one would expect that the U-B Pco2 would now be directly
related to the urine bicarbonate concentration because the latter
should be an index of the lumenal fluid pH. In the present
study, we took advantage of these facts to evaluate how
acidemia might stimulate collecting duct hydrogen ion secretion
in vivo.
Effect of acidemia on collecting duct hydrogen ion secretion
in vivo. The purpose of the studies was to use the aforemen-
tioned pharmacologic effect of amiloride to evaluate the mecha-
nism whereby acidemia stimulates collecting duct hydrogen ion
secretion in vivo. In vivo microperfusion data of Giebisch et a,l
[20] demonstrated that the lumenal fluid pH declined but that
the half time of acidification was decreased in the distal tubule
during metabolic acidosis. In contrast, it was recently shown
that, during mild metabolic acidosis, approximately one half of
the ammonium excreted in the urine was added via the medul-
lary collecting duct [21, 22]; this finding implies that a similar
quantity of protons was also secreted in this portion of the
nephron. Moreover, we have recently shown that acidemia
stimulated collecting duct hydrogen ion secretion in vivo, as
reflected by the U-B Pco2 difference; the mechanisms involved,
however, were not elucidated in those experiments [111.
Lysine infusion resulted in an expansion of the ECF volume
in the studies reported in this manuscript (Table 2). At similar
urine bicarbonate concentrations, amiloride infusion resulted in
only a small fall in the U-B Pco2 difference (Figs. 3—5). These
results are consistent with previously reported observations
that amiloride did not cause the U-B Pco2 to fall appreciably in
dogs with an expanded ECF volume [11].
Our present data also demonstrate that in dogs receiving both
lysine and amiloride, the slope depicting the relationship be-
tween the U-B Pco2 and the urine bicarbonate concentration
was steeper during acidemia (Figs. 3—5) and that the U-B Pco2/
urine bicarbonate concentration ratio was positively correlated
with the blood hydrogen ion concentration (Fig. 6). It would
thus appear that acidemia stimulated hydrogen ion secretion
despite the fact that the amiloride-sensitive component of the
U-B Pco2 was abolished. The mechanism presumably would
involve an increase in the intracellular or a decrease in the
lumenal hydrogen ion concentration. Because the urine pH was
slightly decreased during acidemia (Table 2), the most likely
explanation is that acidemia lowered the intracellular pH of
collecting duct cells. This accelerated collecting duct hydrogen
ion secretion during acidemia may be analogous to the in-
creased proton secretion observed in the isolated perfused
cortical collecting duct of the rabbit [23].
The same positive correlation between the ratio U-B Pco;I
urine bicarbonate concentration and the blood hydrogen ion
concentration was observed in normovolemic dogs treated with
amiloride (Fig. 2), but this relationship was not seen in the
absence of amiloride (Fig. I). One possible explanation for
60 120
UHCO mM
Fig. 5. Effect of urine bicarbonate concentration on the U-B Pco2
during lysine infusion into amiloride-treated dogs with a blood pH
exceeding 7.43. The regression line during alkalemia is U-B Pco2 0.44
UHCO. — 14.4 (N = 52, r = 0.85, P < 0.01). The dashed tine represents
the regression line (V = 0.47x + 3.9) obtained in alkalemic dogs infused
with lysine in the absence of amiloride [12].
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Fig. 6. Effect of blood hydrogen ion concentration on the U-B Pco2
factored by the urine bicarbonate concentration during lysine infusion
into amiloride-treated dogs. The regression line is U-B Pco2IU0, =
0.023 blood [H] — 0.36 (N 205, r = 0.72, P < 0.01). The dashed line
indicates the regression line (V = 0.046x — 0.87) obtained in dogs
infused with lysine in the absence of amiloride [12].
these results is that the U-B PCO2/UHCO relationship was
obscured by the amiloride-sensitive component of collecting
duct hydrogen ion secretion which is relatively prominent under
these conditions.
Why are the lithium- [24] or amiloride- [25] induced models of
distal renal tubular acidosis not generally accompanied by
IBlood pH,>7.43)
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severe acidemia? Because these substances appear to diminish
only the electrical augmentation of collecting duct hydrogen ion
secretion, the presence of a mild metabolic acidosis may
increase the activity of the proton pump, thereby increasing net
acid excretion. This hypothesis is consistent with the findings of
the present study that acidemia accelerated that component of
collecting duct hydrogen ion secretion that is independent of
amiloride.
The very low urinary potassium concentrations observed
during amiloride infusion must reflect almost complete inhibi-
tion of distal secretion of potassium. This finding is comparable
to the marked inhibition of potassium secretion in isolated
perfused cortical collecting tubules of rabbits in the presence of
amiloride [71 but stands in sharp contrast with the partial
inhibition of hydrogen ion secretion as assessed by the U-B
Pco2. This may relate to the fact that most of the urine
potassium is excreted as a result of secretion down a favorable
electrical gradient whereas only a portion of the hydrogen ion
secretion takes place as a result of this process.
In summary, acidemia stimulated the component of the U-B
Pco2 that was not abolished by amiloride, presumably by
decreasing the intracellular pH. This proposed mechanism,
however, must be considered tentative until confirmed by
direct measurements in vivo.
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